Postoperative Mediastinal Radiation for Cancer of the Lung

James D. Cox, Jean Mefferd, Irving D. Kaplan, Jay S. Cooper, Ronald H. Blum, Arthur Boyd, John Mastandrea, Michael T. Kademian, Jerome Marmorstein, Thomas H. Weisenburger, Mitchell H. Gail, John D. Minna, Daniel C. Ihde, Eli J. Glatstein

Research output: Contribution to journalLetter

2 Citations (Scopus)

Abstract

To the Editor: The role of surgical adjuvant radiation therapy for patients with cancer of the lung has been a subject of debate for many years. On the basis of fragmentary data from retrospective studies, we have recommended postoperative irradiation for patients with regional lymph-node metastasis (N1 and N2).1 The report by the Lung Cancer Study Group of its study of postoperative mediastinal irradiation has been eagerly awaited, since it was expected to clarify the issue. The publication of this study (Nov. 27 issue)2 leaves several important questions unanswered. The investigators chose to study only squamous-cell carcinoma in Stages II.

Original languageEnglish (US)
Pages (from-to)1475-1477
Number of pages3
JournalNew England Journal of Medicine
Volume316
Issue number23
DOIs
StatePublished - Jun 4 1987

Fingerprint

Mediastinal Neoplasms
Lung Neoplasms
Radiation
Publications
Squamous Cell Carcinoma
Radiotherapy
Retrospective Studies
Lymph Nodes
Research Personnel
Neoplasm Metastasis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cox, J. D., Mefferd, J., Kaplan, I. D., Cooper, J. S., Blum, R. H., Boyd, A., ... Glatstein, E. J. (1987). Postoperative Mediastinal Radiation for Cancer of the Lung. New England Journal of Medicine, 316(23), 1475-1477. https://doi.org/10.1056/NEJM198706043162310

Postoperative Mediastinal Radiation for Cancer of the Lung. / Cox, James D.; Mefferd, Jean; Kaplan, Irving D.; Cooper, Jay S.; Blum, Ronald H.; Boyd, Arthur; Mastandrea, John; Kademian, Michael T.; Marmorstein, Jerome; Weisenburger, Thomas H.; Gail, Mitchell H.; Minna, John D.; Ihde, Daniel C.; Glatstein, Eli J.

In: New England Journal of Medicine, Vol. 316, No. 23, 04.06.1987, p. 1475-1477.

Research output: Contribution to journalLetter

Cox, JD, Mefferd, J, Kaplan, ID, Cooper, JS, Blum, RH, Boyd, A, Mastandrea, J, Kademian, MT, Marmorstein, J, Weisenburger, TH, Gail, MH, Minna, JD, Ihde, DC & Glatstein, EJ 1987, 'Postoperative Mediastinal Radiation for Cancer of the Lung', New England Journal of Medicine, vol. 316, no. 23, pp. 1475-1477. https://doi.org/10.1056/NEJM198706043162310
Cox JD, Mefferd J, Kaplan ID, Cooper JS, Blum RH, Boyd A et al. Postoperative Mediastinal Radiation for Cancer of the Lung. New England Journal of Medicine. 1987 Jun 4;316(23):1475-1477. https://doi.org/10.1056/NEJM198706043162310
Cox, James D. ; Mefferd, Jean ; Kaplan, Irving D. ; Cooper, Jay S. ; Blum, Ronald H. ; Boyd, Arthur ; Mastandrea, John ; Kademian, Michael T. ; Marmorstein, Jerome ; Weisenburger, Thomas H. ; Gail, Mitchell H. ; Minna, John D. ; Ihde, Daniel C. ; Glatstein, Eli J. / Postoperative Mediastinal Radiation for Cancer of the Lung. In: New England Journal of Medicine. 1987 ; Vol. 316, No. 23. pp. 1475-1477.
@article{cadb6f3924d24acfbbc6190a1fa893be,
title = "Postoperative Mediastinal Radiation for Cancer of the Lung",
abstract = "To the Editor: The role of surgical adjuvant radiation therapy for patients with cancer of the lung has been a subject of debate for many years. On the basis of fragmentary data from retrospective studies, we have recommended postoperative irradiation for patients with regional lymph-node metastasis (N1 and N2).1 The report by the Lung Cancer Study Group of its study of postoperative mediastinal irradiation has been eagerly awaited, since it was expected to clarify the issue. The publication of this study (Nov. 27 issue)2 leaves several important questions unanswered. The investigators chose to study only squamous-cell carcinoma in Stages II.",
author = "Cox, {James D.} and Jean Mefferd and Kaplan, {Irving D.} and Cooper, {Jay S.} and Blum, {Ronald H.} and Arthur Boyd and John Mastandrea and Kademian, {Michael T.} and Jerome Marmorstein and Weisenburger, {Thomas H.} and Gail, {Mitchell H.} and Minna, {John D.} and Ihde, {Daniel C.} and Glatstein, {Eli J.}",
year = "1987",
month = "6",
day = "4",
doi = "10.1056/NEJM198706043162310",
language = "English (US)",
volume = "316",
pages = "1475--1477",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "23",

}

TY - JOUR

T1 - Postoperative Mediastinal Radiation for Cancer of the Lung

AU - Cox, James D.

AU - Mefferd, Jean

AU - Kaplan, Irving D.

AU - Cooper, Jay S.

AU - Blum, Ronald H.

AU - Boyd, Arthur

AU - Mastandrea, John

AU - Kademian, Michael T.

AU - Marmorstein, Jerome

AU - Weisenburger, Thomas H.

AU - Gail, Mitchell H.

AU - Minna, John D.

AU - Ihde, Daniel C.

AU - Glatstein, Eli J.

PY - 1987/6/4

Y1 - 1987/6/4

N2 - To the Editor: The role of surgical adjuvant radiation therapy for patients with cancer of the lung has been a subject of debate for many years. On the basis of fragmentary data from retrospective studies, we have recommended postoperative irradiation for patients with regional lymph-node metastasis (N1 and N2).1 The report by the Lung Cancer Study Group of its study of postoperative mediastinal irradiation has been eagerly awaited, since it was expected to clarify the issue. The publication of this study (Nov. 27 issue)2 leaves several important questions unanswered. The investigators chose to study only squamous-cell carcinoma in Stages II.

AB - To the Editor: The role of surgical adjuvant radiation therapy for patients with cancer of the lung has been a subject of debate for many years. On the basis of fragmentary data from retrospective studies, we have recommended postoperative irradiation for patients with regional lymph-node metastasis (N1 and N2).1 The report by the Lung Cancer Study Group of its study of postoperative mediastinal irradiation has been eagerly awaited, since it was expected to clarify the issue. The publication of this study (Nov. 27 issue)2 leaves several important questions unanswered. The investigators chose to study only squamous-cell carcinoma in Stages II.

UR - http://www.scopus.com/inward/record.url?scp=0023197301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023197301&partnerID=8YFLogxK

U2 - 10.1056/NEJM198706043162310

DO - 10.1056/NEJM198706043162310

M3 - Letter

C2 - 3574427

AN - SCOPUS:0023197301

VL - 316

SP - 1475

EP - 1477

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 23

ER -